Mode
Text Size
Log in / Sign up

Keratinocyte necroptosis contributes to epidermal barrier compromise in inflammatory skin diseases and acute injuriesCell death process may play role in inflammatory skin diseases

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note keratinocyte necroptosis as a potential but context-dependent target for inflammatory skin diseases.

This mini review explores the role of keratinocyte necroptosis in the pathogenesis of inflammatory skin diseases and acute epidermal injuries. The authors synthesize evidence indicating that necroptosis can compromise the epidermal barrier and release damage-associated molecular patterns. These processes are implicated in multiple skin conditions and acute injuries.

Regarding therapeutic potential, the review suggests that necroptosis-related signaling in keratinocytes may represent a viable target for intervention. However, the authors note that the impact of targeting these pathways may vary significantly across different disease contexts. Specifically, the effectiveness of such interventions may depend on the infection status and the specific immune microenvironment.

Limitations include the preliminary nature of the translational evidence. The authors emphasize that identifying disease-specific contributions and appropriate therapeutic windows is essential for clinical feasibility. Clinical application of necroptosis-related signaling as a therapeutic target is not yet established, and its feasibility must be carefully considered based on specific clinical contexts.

How this fits prior evidence

This review addresses a gap in the understanding of cellular mechanisms in inflammatory skin diseases. It complements the existing evidence regarding Opsin 3 as a potential therapeutic target for melanoma and inflammatory skin diseases by providing further insight into the role of keratinocyte necroptosis in barrier compromise and inflammatory signaling.

When your skin is damaged or inflamed, your body's first line of defense is the outer layer. New research looks at a specific way skin cells die called necroptosis. This process can break down the skin barrier and release molecules that trigger inflammation, potentially making skin conditions worse.

This type of cell death is linked to both chronic inflammatory skin diseases and sudden injuries to the skin. Because it plays such a central role in how the skin reacts to damage, it could be a target for new treatments. However, the way it works can change depending on the specific disease, the presence of an infection, or the surrounding immune environment.

While these findings offer a potential path for new therapies, the evidence is still in the early stages. Scientists need to figure out exactly how this process behaves in different clinical settings before it can be used to develop specific treatments. For now, it highlights a key biological mechanism that could help doctors better understand skin health.

What this means for you:
A specific cell death process called necroptosis may drive skin inflammation and could be a target for future treatments.

Common questions

What is necroptosis and how does it affect the skin?

Necroptosis is a specific way that skin cells die. When this happens, it can damage the skin's protective barrier and release molecules that trigger inflammation. This process is linked to both chronic inflammatory skin diseases and sudden injuries to the outer layer of the skin.

Can this process be used to treat skin conditions?

Because necroptosis is involved in skin damage, it may be a target for new treatments. However, the effectiveness of targeting this process depends on the specific disease, whether an infection is present, and the local immune environment. More research is needed to determine its clinical feasibility.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
The skin functions as a barrier against external insults and as an active immune organ. Keratinocytes are central to both roles, maintaining epidermal integrity while coordinating cutaneous immune responses. Necroptosis is a lytic form of regulated cell death that can compromise the epidermal barrier and release damage-associated molecular patterns, thereby linking tissue injury to immune activation. Accumulating evidence implicates keratinocyte necroptosis in multiple inflammatory skin diseases and acute epidermal injuries. This mini review summarizes the molecular regulation of keratinocyte necroptosis, critically appraises evidence for its involvement across distinct pathological contexts, and evaluates therapeutic strategies and associated translational challenges. Mechanistic studies and preliminary translational evidence suggest that necroptosis-related signaling in keratinocytes may represent a therapeutic target. However, the effects of pathway modulation may vary across disease contexts and depend on infection status and the immune microenvironment. Defining the disease-specific contribution of keratinocyte necroptosis and the corresponding therapeutic windows will therefore be essential for evaluating the clinical feasibility of this strategy.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.